BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+4.25%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$1.01B
AUM Growth
+$1.01B
(+5.4%)
Cap. Flow
+$23.9M
Cap. Flow
% of AUM
2.37%
Top 10 Holdings %
Top 10 Hldgs %
32.72%
Holding
140
New
6
Increased
28
Reduced
48
Closed
16
Top Buys
| 1 |
Teladoc Health
TDOC
|
$18.9M |
| 2 |
Humana
HUM
|
$13.5M |
| 3 |
KTWO
K2M Group Holdings, Inc
KTWO
|
$12.7M |
| 4 |
Esperion Therapeutics
ESPR
|
$11.9M |
| 5 |
FIT
Fitbit, Inc. Class A common stock
FIT
|
$11.7M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$20.4M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$11.6M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$10.6M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$9.94M |
| 5 |
Tenet Healthcare
THC
|
$9.34M |
Sector Composition
| 1 | Healthcare | 95.24% |
| 2 | Industrials | 0.39% |
| 3 | Financials | 0.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HRC
26
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $13.7M | 1.36% | 157,919 -12,020 | -7% | -$1.05M |
|
27
Supernus Pharmaceuticals
SUPN
$2.53B
| $13.2M | 1.31% | 288,800 +48,400 | +20% | +$2.22M |
|
28
Centene
CNC
$14.3B
| $12.8M | 1.27% | 120,020 +4,630 | +4% | +$495K |
|
|
KTWO
29
DELISTED
K2M Group Holdings, Inc
KTWO
| $12.7M | 1.25% | +667,941 | New | +$12.7M |
|
30
Biogen
BIIB
$19.4B
| $12.7M | 1.25% | 46,200 -6,100 | -12% | -$1.67M |
|
31
Gilead Sciences
GILD
$140B
| $12.6M | 1.25% | 167,200 -13,900 | -8% | -$1.05M |
|
|
32
Esperion Therapeutics
ESPR
$448M
| $12.5M | 1.24% | 172,720 +164,920 | +2,114% | +$11.9M |
|
33
Amgen
AMGN
$155B
| $11.7M | 1.16% | 68,700 -13,050 | -16% | -$2.22M |
|
|
FIT
34
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $11.7M | 1.16% | +2,295,400 | New | +$11.7M |
|
35
Becton Dickinson
BDX
$55.3B
| $10.8M | 1.07% | 50,000 -5,000 | -9% | -$1.08M |
|
|
WMGI
36
DELISTED
Wright Medical Group Inc
WMGI
| $10.7M | 1.06% | 541,801 | – | – |
|
37
Integra LifeSciences
IART
$1.18B
| $10.6M | 1.05% | 191,000 +8,800 | +5% | +$487K |
|
38
ResMed
RMD
$40.2B
| $10.5M | 1.04% | 107,000 +60,000 | +128% | +$5.91M |
|
39
Cigna
CI
$80.3B
| $9.67M | 0.96% | 57,650 | – | – |
|
40
Labcorp
LH
$23.1B
| $9.66M | 0.96% | 59,730 +2,910 | +5% | +$471K |
|
41
Viatris
VTRS
$12.3B
| $9.63M | 0.95% | 233,950 -2,350 | -1% | -$96.8K |
|
42
Regeneron Pharmaceuticals
REGN
$61.5B
| $9.43M | 0.93% | 27,380 -420 | -2% | -$145K |
|
43
Zimmer Biomet
ZBH
$21B
| $9.05M | 0.9% | 83,000 | – | – |
|
44
HUTCHMED
HCM
$2.58B
| $8.94M | 0.89% | 302,420 +168,570 | +126% | +$4.98M |
|
|
ALDR
45
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $8.9M | 0.88% | 700,464 +669,864 | +2,189% | +$8.51M |
|
|
SHPG
46
DELISTED
Shire pic
SHPG
| $8.73M | 0.86% | 58,435 +2,000 | +4% | +$299K |
|
47
LivaNova
LIVN
$3.08B
| $8.38M | 0.83% | 94,724 -52,545 | -36% | -$4.65M |
|
|
TSRO
48
DELISTED
TESARO, Inc.
TSRO
| $8.27M | 0.82% | 144,802 +72,702 | +101% | +$4.15M |
|
|
ABMD
49
DELISTED
Abiomed Inc
ABMD
| $7.93M | 0.79% | 27,250 +250 | +0.9% | +$72.7K |
|
50
Insmed
INSM
$28.8B
| $7.53M | 0.75% | +334,489 | New | +$7.53M |
|